ZBH

SEC source: 0000911916-20-000060 · edgar.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,692 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2020.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2020.

SEC source: 0000911916-20-000060 · edgar.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,258

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0000911916-20-000060 · edgar.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,170

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 88 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on December 31, 2019.

SEC source: 0000911916-20-000059 · edgar.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,610 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2020.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2020.

SEC source: 0000911916-20-000059 · edgar.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,064

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0000911916-20-000059 · edgar.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,529

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 197 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan and pursuant to dividend reinvestment between October 31, 2019 and January 31, 2020.

SEC source: 0000911916-20-000057 · edgar.xml · derivative · entry 2

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,640 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Earned RSUs vested on February 26, 2020.

F2 · derivative.expiration_date: Earned RSUs vested on February 26, 2020.

SEC source: 0000911916-20-000057 · edgar.xml · nonDerivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-20-000033 · edgar.xml · derivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,296

Underlying: Common Stock · 23,296 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000039 · edgar.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,355

Underlying: Common Stock · 25,355 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000038 · edgar.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,414

Underlying: Common Stock · 40,414 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000037 · edgar.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,996

Underlying: Common Stock · 41,996 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000036 · edgar.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,984

Underlying: Common Stock · 22,984 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000035 · edgar.xml · derivative · entry 1

Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,735

Underlying: Common Stock · 6,735 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000034 · edgar.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,480

Underlying: Common Stock · 158,480 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-20-000025 · edgar.xml · derivative · entry 2

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,756

Underlying: Common Stock · 1,756 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs.

F5 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020.

F5 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020.

F4 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs.

F4 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs.

SEC source: 0000911916-20-000025 · edgar.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,208

Underlying: Common Stock · 2,208 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2020.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2020.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs.

SEC source: 0000911916-20-000024 · edgar.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,692

Underlying: Common Stock · 2,692 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 2,692 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 2,692 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 2,692 RSUs.

SEC source: 0000911916-20-000023 · edgar.xml · derivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,610

Underlying: Common Stock · 1,610 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,610 RSUs.

F5 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020.

F5 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020.

F4 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,610 RSUs.

F4 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,610 RSUs.

SEC source: 0000911916-20-000023 · edgar.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,037

Underlying: Common Stock · 2,037 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,037 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2020.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2020.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,037 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,037 RSUs.

SEC source: 0000911916-20-000022 · edgar.xml · derivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,716

Underlying: Common Stock · 9,716 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 9,716 RSUs.

F5 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020.

F5 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020.

F4 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 9,716 RSUs.

F4 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 9,716 RSUs.

SEC source: 0000911916-20-000022 · edgar.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,056

Underlying: Common Stock · 12,056 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 12,056 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2020.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2020.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 12,056 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 12,056 RSUs.

SEC source: 0000911916-20-000021 · edgar.xml · derivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,640

Underlying: Common Stock · 1,640 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs.

SEC source: 0000911916-20-000007 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,087.316

Underlying: Common Stock · 184.564 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 17.231 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000013 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,006.165

Underlying: Common Stock · 184.564 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 10.130 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000011 · edgar.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,667.057

Underlying: Common Stock · 184.564 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 92.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 92.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 2.580 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000012 · edgar.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,084.41

Underlying: Common Stock · 92.282 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 1.726 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000010 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,181.778

Underlying: Common Stock · 218.121 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 41.697 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000009 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,572.518

Underlying: Common Stock · 226.51 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 33.662 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000008 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,948.875

Underlying: Common Stock · 184.564 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.770 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000002 · edgar.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,738.689

Underlying: Common Stock · 209.732 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.321 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-20-000004 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,981.328

Underlying: Common Stock · 209.732 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 20.483 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000192 · edgar.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,625

Underlying: Common Stock · 8,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 8,625 of the RSUs vested on each of December 19, 2018 and December 19, 2019. The remaining 8,625 RSUs will vest on December 19, 2020.

F3 · derivative.expiration_date: 8,625 of the RSUs vested on each of December 19, 2018 and December 19, 2019. The remaining 8,625 RSUs will vest on December 19, 2020.

SEC source: 0000911916-19-000192 · edgar.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,066

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0000911916-19-000192 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-19-000186 · edgar.xml · derivative · entry 9

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,572

Underlying: Common Stock · 1,523 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

SEC source: 0000911916-19-000186 · edgar.xml · derivative · entry 8

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,775

Underlying: Common Stock · 925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

SEC source: 0000911916-19-000186 · edgar.xml · derivative · entry 7

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,267

Underlying: Common Stock · 1,088 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2019. The remaining RSUs vest annually in equal portions on December 3, 2020, December 3, 2021 and December 3, 2022.

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 6

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,390

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 5

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 4

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,554

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 3

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,047

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0000911916-19-000186 · edgar.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 144 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 28, 2019.

SEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 15

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,340

Underlying: Common Stock · 2,780 shares

Expires 2028-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: 2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022.

SEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 14

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,910

Underlying: Common Stock · 2,910 shares

Expires 2027-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: 1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021.

SEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 13

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,612

Underlying: Common Stock · 1,613 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: 806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021.

SEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 12

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,572

Underlying: Common Stock · 4,718 shares

Expires 2026-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020.

SEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 11

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,150 shares

Expires 2025-06-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019.

SEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 10

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 757

F5 · price: Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.